Status:
COMPLETED
On Demand Treatment of Reflux Disease
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Ferrosan AS
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)
Detailed Description
A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.
Eligibility Criteria
Inclusion
- Mild and moderate reflux symptoms Age \> 17 years Informed consent -
Exclusion
- Other conditions that might explain the symptoms Abuse of drugs or alcohol
- \-
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00184522
Start Date
August 1 2002
End Date
December 1 2004
Last Update
August 9 2011
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Gjøvik Specialist Centre
Gjøvik, Norway, 2800
2
Sykehuset Innlandet HF, Gjøvik
Gjøvik, Norway, 2819
3
Sykehuset Innlandet HF, Hamar
Hamar, Norway
4
Sykehuset Innlandet HF, Kongsvinger
Kongsvinger, Norway